STAND. COM. REP. NO. 1077-18
RE: H.B. No. 2384
Honorable Scott K. Saiki
Speaker, House of Representatives
Twenty-Ninth State Legislature
Regular Session of 2018
State of Hawaii
Your Committee on Judiciary, to which was referred H.B. No. 2384, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"
begs leave to report as follows:
The purpose of this measure is to amend the Uniform Controlled Substances Act to provide flexibility and clear guidance for practitioners who prescribe, administer, or dispense controlled substances for patients undergoing medically managed withdrawal or detoxification treatment.
Specifically, the measure:
(1) Excludes certain substances from Schedule II to conform with the Federal Drug Enforcement Administration's updated schedules of controlled substances; and
(2) Establishes registration and compliance requirements for medical practitioners and hospitals that prescribe, administer, and dispense controlled substances to patients undergoing medically managed withdrawal.
The Department of Health, Department of Public Safety, The Drug Policy Forum of Hawaii, Hawaii Substance Abuse Coalition, and Oahu County Committee on Legislative Priorities of the Democratic Party of Hawaii supported this measure.
As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2384, H.D. 1, and recommends that it pass Third Reading.
Respectfully submitted on behalf of the members of the Committee on Judiciary,
SCOTT Y. NISHIMOTO, Chair